Phase 3b open-label RCT in 400 patients after recent acute coronary syndrome: inclisiran plus usual care vs usual care raised LDL-C <70 mg/dL attainment at day 330 (66.7% vs 28.1%; OR 5.42) with a -46.9% difference in LDL-C change.
RCTn = 400
Knowlton et al. Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial